Revenue | ₹1.62Cr |
Net Profits | ₹0.03Cr |
Net Profit Margins | 1.85% |
Venmax Drugs & Pharmaceuticals Ltd’s revenue jumped 710% since last year same period to ₹1.62Cr in the Q3 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 22.73% jump in its revenue since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 106% since last year same period to ₹0.03Cr in the Q3 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 50% jump in its net profits since last 3-months.
Venmax Drugs & Pharmaceuticals Ltd’s net profit margin jumped 100.74% since last year same period to 1.85% in the Q3 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 22.22% jumped in its net profit margins since last 3-months.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹1.62Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was ₹0.03Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2025 was 1.85%.
The revenue for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.20Cr.
The net profit for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.50Cr.
The net profit margin for Venmax Drugs & Pharmaceuticals Ltd in the Q3 results 2024 was -250.00%.